Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 8.28
(-0.12%)
CNY 8.28
(-0.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.07 Billion | 2.77 Billion | 3.26 Billion | 2.89 Billion | 2.77 Billion | 2.69 Billion |
| Cost of Revenue | 621.05 Million | 617.51 Million | 575.65 Million | 588.37 Million | 721.5 Million | 745.03 Million |
| Gross Profit | 2.45 Billion | 2.16 Billion | 2.69 Billion | 2.3 Billion | 2.05 Billion | 1.94 Billion |
| Operating Expenses | 1.08 Billion | 1.27 Billion | 1.42 Billion | 1.16 Billion | 1.1 Billion | 957.77 Million |
| Selling, General and Administrative Expenses | 1.02 Billion | 978.4 Million | 1.08 Billion | 957.9 Million | 901.47 Million | 759.88 Million |
| Research and Development Expenses | 106.9 Million | 146.7 Million | 166.85 Million | 106.92 Million | 78.04 Million | 97.65 Million |
| Other Expenses | -5.62 Million | 145.27 Million | 171.81 Million | 99.02 Million | 121.85 Million | -15.45 Million |
| Cost and Expenses | 1.71 Billion | 1.88 Billion | 1.99 Billion | 1.75 Billion | 1.82 Billion | 1.7 Billion |
| Operating Income | 1.36 Billion | 1.82 Billion | 1.54 Billion | 1.18 Billion | 967.84 Million | 992.98 Million |
| Interest Expense | 7.21 Million | 283.24 Thousand | 225.74 Thousand | 10.16 Million | 20.56 Million | 13.45 Million |
| Income Tax Expense | 197.97 Million | 247.68 Million | 225.85 Million | 177.8 Million | 142.85 Million | 138.6 Million |
| Earnings before Tax | 1.36 Billion | 1.82 Billion | 1.53 Billion | 1.1 Billion | 952.49 Million | 977.53 Million |
| Net Income | 1.16 Billion | 1.58 Billion | 1.3 Billion | 929.91 Million | 811.2 Million | 838.6 Million |
| Earnings Per Share Basic | 0.59 | 0.80 | 0.64 | 0.46 | 0.40 | 0.41 |
| Earnings Per Share Diluted | 0.59 | 0.80 | 0.64 | 0.46 | 0.40 | 0.41 |
| Weighted Average Shares Outstanding | 1.97 Billion | 1.97 Billion | 2.04 Billion | 2.02 Billion | 2.02 Billion | 2.04 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.97 Billion | 1.97 Billion | 2.04 Billion | 2.02 Billion | 2.02 Billion | 2.04 Billion |
| Gross Margin | 0.80 | 0.78 | 0.82 | 0.80 | 0.74 | 0.72 |
| EBIT Margin | 0.51 | 0.71 | 0.52 | 0.44 | 0.41 | 0.43 |
| Profit Margin | 0.38 | 0.57 | 0.40 | 0.32 | 0.29 | 0.31 |
| EBITDA | 1.55 Billion | 1.94 Billion | 1.67 Billion | 1.27 Billion | 1.12 Billion | 1.16 Billion |
| Earnings Before Tax Margin | 0.44 | 0.66 | 0.47 | 0.41 | 0.35 | 0.37 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 707.7 Million | 146.82 Million | 587.73 Million | 980.26 Million | 3.06 Billion | 725.17 Million |
| Cost of Revenue | 169.45 Million | 101.58 Million | 126.07 Million | 188.94 Million | 689.74 Million | 136.58 Million |
| Gross Profit | 538.25 Million | 45.23 Million | 461.66 Million | 791.32 Million | 2.37 Billion | 588.59 Million |
| Operating Expenses | 410.32 Million | 356.49 Million | 247.2 Million | 337.39 Million | 1.1 Billion | 295.95 Million |
| Selling, General and Administrative Expenses | 522.06 Million | 285.87 Million | 220.19 Million | 293.81 Million | - | 333.35 Million |
| Research and Development Expenses | 27.94 Million | 6.06 Million | 27.01 Million | 29.66 Million | - | 21.05 Million |
| Other Expenses | -139.68 Million | -64.55 Million | -121.14 Thousand | -13.92 Million | -5.62 Million | -2.21 Million |
| Cost and Expenses | 579.77 Million | 458.07 Million | 373.28 Million | 526.34 Million | 1.79 Billion | 432.53 Million |
| Operating Income | 181.04 Million | -311.25 Million | 214.45 Million | 453.92 Million | 1.27 Billion | 316.5 Million |
| Interest Expense | 3.61 Million | 3.25 Million | 2.39 Million | 4.04 Million | 4.53 Million | 391 Thousand |
| Income Tax Expense | 19.07 Million | -91.88 Million | 24.07 Million | 79.86 Million | 197.97 Million | 38.94 Million |
| Earnings before Tax | 183.16 Million | -564.57 Million | 218.51 Million | 457.81 Million | 1.27 Billion | 314.28 Million |
| Net Income | 164.11 Million | -445.16 Million | 214.67 Million | 407.68 Million | 1.16 Billion | 275.35 Million |
| Earnings Per Share Basic | 0.08 | -0.22 | 0.11 | 0.21 | - | 0.14 |
| Earnings Per Share Diluted | 0.08 | -0.22 | 0.11 | 0.21 | - | 0.14 |
| Weighted Average Shares Outstanding | 1.94 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.94 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion | 1.97 Billion |
| Gross Margin | 0.76 | 0.31 | 0.79 | 0.81 | 0.77 | 0.81 |
| EBIT Margin | 0.26 | -1.79 | 0.41 | 0.52 | - | 0.44 |
| Profit Margin | 0.23 | -3.03 | 0.37 | 0.42 | 0.38 | 0.38 |
| EBITDA | 186.78 Million | -262.6 Million | 241.09 Million | 507.18 Million | - | 320.53 Million |
| Earnings Before Tax Margin | 0.26 | -2.12 | 0.36 | 0.46 | 0.42 | 0.44 |
8076
YIPS
STMEF
601198
600638
LAES